Asvik Pharma And Chemicals Private Limited, a active private limited company, was established on 29 November 1996 in Mulund West, Maharashtra, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24230MH1996PTC104252. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.50 Cr.
It upholds a compliant status. Employing 22 professional, Its leadership includes Usha Shrinivas Acharya (Director), Anand Shriniwas Acharya (Director), Shripati Narahari Acharya (Director). It holds no open charges and ₹2.00 Cr settled loans. Its latest AGM occurred on 11 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sai Jyot, Office No.105, 1St Floor, Neepa Chs, Junction Of S. N. Road & S. L, . Road,, Mulund West, Maharashtra, 400080.
U24230MH1996PTC104252
104252
29 November 1996
₹2.00 Cr
₹1.50 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Asvik Pharma And Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Usha Shrinivas Acharya | Director | 01 Sep 2000 | Current |
| Anand Shriniwas Acharya | Director | 01 Sep 1999 | Current |
| Shripati Narahari Acharya | Director | 01 Sep 2000 | Current |
| Shrikant Narahari Acharya | Director | 01 Sep 1999 | Current |
| Venkatraman Narayan Bhagwat | Director | 25 Jul 2003 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Asvik Pharma And Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 54.5% decrease. The company also saw a slight improvement in profitability, with a 5.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 50.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Asvik Pharma And Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹20,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2012 | The Zoroastrian Co-Operative Bank Limited | ₹6.00 M | Satisfied |
| 28 Jun 2012 | The Zoroastrian Co-Operative Bank Limited | ₹9.00 M | Satisfied |
| 05 Apr 2011 | The Saraswat Co-Operative Bank Limited | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Asvik Pharma And Chemicals has a workforce of 22 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Asvik Pharma And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asvik Pharma And Chemicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Asvik Pharma And Chemicals Private Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records. was documented.
Progress on Asvik Pharma And Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge registered on 28 Jun 2012 via Charge ID 10369327 with The Zoroastrian Co-Operative Bank Limited was fully satisfied on 25 Jul 2018. was documented.
Progress on A charge registered on 30 Jun 2012 via Charge ID 10369328 with The Zoroastrian Co-Operative Bank Limited was fully satisfied on 27 Sep 2013. was documented.
A charge registered on 05 Apr 2011 via Charge ID 10284951 with The Saraswat Co-Operative Bank Limited was fully satisfied on 29 Aug 2012. was recorded as a recent event.
A charge with The Zoroastrian Co-Operative Bank Limited amounted to Rs. 0.60 Cr with Charge ID 10369328 was registered on 30 Jun 2012. was recorded as a recent event.
The CIN of Asvik Pharma And Chemicals Private Limited is U24230MH1996PTC104252.
Asvik Pharma And Chemicals Private Limited is headquartered at Sai Jyot, Office No.105, 1St Floor, Neepa Chs, Junction Of S. N. Road & S. L, . Road,, Mulund West, Maharashtra, 400080.
Asvik Pharma And Chemicals Private Limited was incorporated on 29 November 1996.
The current directors of Asvik Pharma And Chemicals Private Limited are
The primary industry of Asvik Pharma And Chemicals Private Limited is Manufacturing.
Asvik Pharma And Chemicals Private Limited is unlisted.
The authorized capital of Asvik Pharma And Chemicals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.50 Cr.
The compliance status of Asvik Pharma And Chemicals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX